An invalid vocabulary is selected. Please change it in the options.
Title Creditssort ascending Start date - Expiration date
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 2.00 12/21/2023 - 12:00am to 12/21/2024 - 12:00am
The Evolving Landscape in CLL/SLL: Best Practice Clinical Applications of Current Evidence and New Guideline Recommendations 1.75 07/21/2023 - 12:00am to 07/21/2024 - 12:00am
Advances in Hepatocellular and Biliary Tract Cancers Impacting Patient Outcomes 1.75 07/21/2023 - 12:00am to 07/21/2024 - 12:00am
Clinical Considerations in Renal Cell Carcinoma: Current Evidence, Guideline Recommendations, and a View to the Future 1.75 07/21/2023 - 12:00am to 07/21/2024 - 12:00am
Unlocking the Potential of Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC: The Role of Checkpoint Inhibitors 1.75 08/09/2023 - 12:00am to 08/09/2024 - 12:00am
Advances in the Management of Metastatic Castration-Resistant Prostate Cancer: Expert Guidance and Resources for the Interdisciplinary Team 1.25 12/21/2023 - 12:00am to 12/21/2024 - 12:00am
What Drives Reimbursement for Biomarker Testing? 1.25 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Neoadjuvant/Adjuvant Treatment for Breast Cancer with SABCS Updates 1.25 03/15/2024 - 12:00am to 03/15/2025 - 12:00am
Locoregional Management of Breast Cancer with SABCS Updates 1.25 03/15/2024 - 12:00am to 03/15/2025 - 12:00am
NCCN Guidelines® Insights - Breast Cancer Screening and Diagnosis, Version 1.2023 1.00 09/10/2023 - 12:00am to 09/10/2024 - 12:00am
Archived Monthly Oncology Tumor Boards: Management of Thyroid Carcinomas 1.00 10/02/2023 - 12:00am to 10/02/2024 - 12:00am
Bone Disease Management and Infections in Multiple Myeloma 1.00 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Monthly Oncology Tumor Boards: Updates in Treatment of Hairy Cell Leukemia 1.00 03/19/2024 - 12:00am to 08/04/2024 - 12:00am
NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024 1.00 10/10/2023 - 12:00am to 10/10/2024 - 12:00am
Archived Monthly Oncology Tumor Boards: Identification and Management of Immuno-Oncology Targeted Therapy-Related Adverse Events in Renal Cell... 1.00 10/26/2023 - 12:00am to 10/26/2024 - 12:00am

Pages